Faculty Opinions recommendation of Telmisartan, ramipril, or both in patients at high risk for vascular events.
Year: 2008
Type: peer-review
Author: Sripal Bangalore
Institutions: NYU Langone Health, New York University
Language: English
Subfield: Cardiology and Cardiovascular Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W4240458577
